These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3328677)

  • 21. Mea culpa.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2008 Aug; 5(8):409. PubMed ID: 18670441
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of Crohn's disease with 5-ASA.
    Katz J
    Am J Gastroenterol; 1993 Sep; 88(9):1315-7. PubMed ID: 8362823
    [No Abstract]   [Full Text] [Related]  

  • 23. Asacol in inflammatory bowel disease.
    Oakes RA
    N Z Med J; 1987 May; 100(824):325. PubMed ID: 3451096
    [No Abstract]   [Full Text] [Related]  

  • 24. [Crohn disease and ulcerative colitis--newer therapeutic approaches].
    Ewe K
    Z Gastroenterol; 1993 Feb; 31(2):151-5. PubMed ID: 8096666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of diversion colitis with 5-aminosalicylic acid enemas: comparison with betamethasone enemas.
    Triantafillidis JK; Nicolakis D; Mountaneas G; Pomonis E
    Am J Gastroenterol; 1991 Oct; 86(10):1552-3. PubMed ID: 1928058
    [No Abstract]   [Full Text] [Related]  

  • 26. Olsalazine as an alternative therapy in a patient with sulfasalazine-induced eosinophilic pneumonia.
    Scherpenisse J; van der Valk PD; van den Bosch JM; van Hees PA; Nadorp JH
    J Clin Gastroenterol; 1988 Apr; 10(2):218-20. PubMed ID: 2901442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.
    van Hees PA; Bakker JH; van Tongeren JH
    Gut; 1980 Jul; 21(7):632-5. PubMed ID: 6107263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical treatment of inflammatory bowel disease.
    Singhal A; Kar P
    J Assoc Physicians India; 1995 Sep; 43(9):627-31. PubMed ID: 8773067
    [No Abstract]   [Full Text] [Related]  

  • 29. [Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].
    Rubinstein BE
    Ugeskr Laeger; 1982 Feb; 144(5):304-6. PubMed ID: 6122297
    [No Abstract]   [Full Text] [Related]  

  • 30. Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway.
    Donowitz M
    Gastroenterology; 1985 Feb; 88(2):580-7. PubMed ID: 2856909
    [No Abstract]   [Full Text] [Related]  

  • 31. [Salicylates in the treatment of Crohn disease].
    Mangiarotti R; Prantera C
    Ann Ital Chir; 1994; 65(3):279-81. PubMed ID: 7887577
    [No Abstract]   [Full Text] [Related]  

  • 32. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].
    Smilde TJ; van Liebergen FJ; Koolen MI; Gerlag PG; Assmann KJ; Berden JH
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2557-61. PubMed ID: 7830805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pentasa (mesalazine) and pregnancy].
    Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
    Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemistry, pharmacology, pharmacokinetics, and clinical applications of mesalamine for the treatment of inflammatory bowel disease.
    Small RE; Schraa CC
    Pharmacotherapy; 1994; 14(4):385-98. PubMed ID: 7937276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine and ulcerative colitis.
    Griffel L; Das KM
    Natl Med J India; 1994; 7(5):222-3. PubMed ID: 7827603
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term therapy of Crohn disease].
    Schölmerich J
    Internist (Berl); 1993 Dec; 34(12):1115-21. PubMed ID: 8106207
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changing treatment of inflammatory bowel diseases].
    Karvonen AL; Matikainen M; Turunen U
    Duodecim; 1994; 110(20):1945-54. PubMed ID: 7555809
    [No Abstract]   [Full Text] [Related]  

  • 39. Mesalamine therapy in Reiter's syndrome.
    Thomson GT; McKibbon C; Inman RD
    J Rheumatol; 1994 Mar; 21(3):570-2. PubMed ID: 8006906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA
    Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.